OutSmart Cancer - Precision Oncology. Less Guess Work. More Life!

Dr. Dino Prato - Envita Medical Centers

OutSmart Cancer is the podcast for people who refuse to settle for one-size-fits-all cancer care. Hosted by Dr. Dino Prato, founder of Envita Medical Centers, this show offers expert insight into the world of precision oncology, integrative treatments, and the hidden factors that make cancer so hard to treat — and what to do about them. For the last 25 years, Dr. Prato and his team have helped thousands of patients that have failed the largest hospitals utilizing the techniques and technology discussed in this series. Whether you’ve been newly diagnosed, are navigating treatment resistance, or want a second opinion grounded in science and compassion, you’ll hear empowering discussions on: DNA, RNA, and immune-based targeting, the truth behind standard protocols, what most doctors miss in treatment planning, stories of hope from patients who’ve been told “there’s nothing more we can do” We believe in personalized, data-driven medicine — not protocol-based guessing.You don’t have to fight cancer blindly. You can OutSmart it. Disclaimer:  This podcast is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before making medical decisions. Results vary and no specific outcomes are guaranteed. Some treatments may not be FDA-approved or available in all locations. Testimonials reflect individual experiences and may not represent typical outcomes. Certain therapies may be offered only at Envita’s international clinic in Hermosillo, Mexico. 

  1. 18H AGO

    Why Big Pharma Silenced These Cancer Pioneers

    The history of cancer treatment is not the clean, linear story most of us were taught. It’s a story of brilliant pioneers, fierce resistance, political power, money, and ideas that were once ridiculed — only to later become foundations of modern medicine. In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, lifts the veil on the forgotten innovators who helped shape today’s precision oncology. From Samuel Hahnemann’s focus on individualized care, to Otto Warburg’s metabolic discoveries, to Judah Folkman’s angiogenesis theory and Steven Rosenberg’s early immunotherapy breakthroughs — many of today’s “standard” ideas were once mocked, suppressed, or criminalized. Dr. Prato walks through how the Flexner Report and the rise of pharmaceutical-driven medicine narrowed the focus of healthcare, sidelining nutrition, metabolism, immune intelligence, and personalization. At the same time, figures like Palmer, Still, Lust, Ravici, Nieper, Gerson, and others pushed boundaries — sometimes too far, sometimes imperfectly — but often planting seeds that modern science later validated. The episode culminates in the Hallmarks of Cancer, the framework that finally unified genetics, metabolism, angiogenesis, and immune evasion — and paved the way for today’s N-of-1, data-driven precision oncology, powered by DNA sequencing, RNA transcriptomics, immune profiling, spatial biology, and AI-guided decision-making. 🎯 What You’ll Learn in This Episode: • Why many breakthrough cancer ideas were once ridiculed or suppressed • How money, patents, and power shaped modern oncology • The origins of metabolic, immune, and angiogenesis-based cancer therapies • Why nutrition, lifestyle, and metabolism were removed from medical training • How the Hallmarks of Cancer unified decades of competing theories • Why cancer is heterogeneous and cannot be treated one-size-fits-all • How N-of-1 precision oncology replaces dogma with data • Why humility, curiosity, and testing matter more than ideology 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 “Progress doesn’t come from defending dogma — it comes from letting the data lead.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

    16 min
  2. 1D AGO

    Complete Remission Without Chemo | The Immune-Centric Approach That Works

    When Fran was diagnosed with metastatic non-small cell lung cancer with brain metastases, she was offered one option: palliative radiation and more chemotherapy. She said no. Not because she gave up — but because she wanted a plan built for her, not a one-size-fits-all protocol. In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, shares how precision oncology and immune-centric care helped Fran achieve a complete response — without traditional chemotherapy. Lung cancer is one of the most immunogenic cancers, yet standard immunotherapy often fails long-term because it isn’t properly targeted. Dr. Prato explains how deep multi-omics mapping — including DNA sequencing, RNA transcriptomics, and immune spatial biology — revealed the exact immune targets needed to design Fran’s treatment. Using genetically targeted fractionated chemotherapy, custom-built immunotherapy, and autologous NK and dendritic cell therapies matched to her DAMPS, the immune system was trained to recognize and eliminate cancer throughout the body — including across the blood–brain barrier. Instead of exhausting the immune system with high-dose chemo or palliative radiation, this approach focused on immunogenic cell death, real-time liquid biopsy monitoring, metabolic support, and precision drug selection (on-label, off-label, repurposed, and phytotherapeutic). The result: tumor clearance, restored energy, and durable immune control. 🎯 What You’ll Learn in This Episode: • Why lung cancer is highly responsive to immunotherapy — when targeted correctly • Why PD-1 inhibitors often fail without immune spatial biology • How DAMPS guide immune training and immunogenic cell death • The role of NK cells and dendritic cells in clearing metastatic disease • How microdosed, targeted chemo reaches the brain without severe toxicity • Why DNA alone isn’t enough — and RNA + immune mapping change everything • How liquid biopsies (CTCs, ctDNA, methylation) monitor remission early • Why precision oncology replaces “step therapy” with a custom playbook 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 “Refusing chemo doesn’t mean refusing hope — it means choosing precision.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at: https://www.scirp.org/journal/pap

    7 min
  3. 2D AGO

    Can Our BODY'S Natural Healing Power FIGHT Cancer With Cell Vaccines?

    What if the most powerful cancer treatment isn’t a drug — but your own body? In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, challenges the war-based model of oncology and explains why the immune system is the most important anti-cancer weapon we have. Long before chemotherapy and radiation existed, the body was already eliminating early cancer cells thousands of times a day. When cancer takes hold, it’s not because the immune system disappeared — it’s because it was misdirected, suppressed, or never given the right information. Dr. Prato walks through the uncomfortable history of chemotherapy and radiation, their origins in warfare, and why a “kill at any cost” strategy often damages the very system needed for long-term recovery. He explains how precision oncology, N-of-1 care, and immune-centered strategies focus on restoring the body’s terrain, correcting root causes, and retraining natural killer cells and dendritic cells to recognize and eliminate cancer. From chronic inflammation, infections, toxins, stress, and poor sleep to immune exhaustion caused by aggressive treatments, this episode connects the dots between biology, terrain, and healing. It also introduces how AAIT (autologous adaptive immunotherapy), deep multi-omics mapping, targeted microdosing, nutrition, gut health, and lifestyle restoration work together to support durable immune function and better outcomes. 🎯 What You’ll Learn in This Episode: • Why the immune system is the most important anti-cancer therapy • How NK cells and dendritic cells work together to eliminate cancer • Why high-dose chemo and radiation often weaken immune surveillance • What DAMPS are and how the right signals activate immune killing • How toxins, infections, stress, and poor sleep suppress immunity • Why N-of-1 precision oncology replaces one-size-fits-all treatment • The key questions every patient should ask their oncologist • How diet, gut health, faith, and mindset influence immune resilience 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

    16 min
  4. 3D AGO

    What if a PERSONALIZED Cancer Plan Could Change Everything?

    Most cancer care still treats populations — not people. In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, introduces OncoMeta, a revolutionary precision ecosystem that designs custom cancer treatment programs based entirely on each patient’s unique biology. Instead of guessing, OncoMeta maps your DNA, RNA, and immune spatial biology to reveal every cancer driver and immune blockade — then builds personalized medications, delivery systems, and immune retraining therapies around it. This next-generation model moves beyond standard “one-size-fits-all” guidelines to a fully integrated system combining molecular mapping, targeted microdosing, and immune activation. The result: smarter drug delivery, fewer side effects, and higher response rates. 🎯 What You’ll Learn in This Episode: • Why standard cancer treatments fail to account for immune terrain and tumor microenvironments • How OncoMeta integrates DNA, RNA, and immune spatial biology for deep targeting • The role of precision mapping in designing microdosed, immune-centered therapies • Why less chemo, given precisely, often delivers better results • How interventional oncology delivers medication directly to the tumor site • Why immune-centric care leads to long-term remission and better quality of life 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak to a care coordinator: 866-830-4576 “You don’t need more treatment — you need the right treatment. Precision changes everything.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

    15 min
  5. 4D AGO

    How Artificial Intelligence Can Supercharge Your Cancer Treatment

    Imagine scanning a tumor like a 3D object — then generating a custom treatment plan built entirely around your biology. That’s generative oncology, the future of cancer care. In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, explains how AI + physician intelligence + multi-omics testing work together to design N-of-1 treatment plans for each patient. Instead of relying on 10–20 markers, generative oncology uses thousands of data points: DNA sequencing, RNA transcriptomics, immune profiling, and spatial biology to build a “heat map” of the cancer’s drivers, resistance pathways, and immune barriers. With this information, doctors can custom-design targeted therapies — on-label, off-label, repurposed drugs, phytotherapeutics, oxygen therapies, nanoparticles, immune biologics (NK & dendritic cells), and even personalized vaccines. Combined with micro-dosed delivery and interventional oncology, precision care increases targeting while reducing toxicity and improving quality of life. 🎯 What You’ll Learn in This Episode: • What generative oncology is and how it differs from standard care • How DNA, RNA, immune profiling & spatial biology reveal thousands of targets • Why cancer is bimodal — metabolic + mutational — and must be treated that way • How AI helps build custom treatment plans without replacing physicians • Why NK cells, dendritic cells & DAMPS signaling are essential for long-term control • How repurposed drugs and phytotherapeutics are selected through heat-map targeting • How micro-dosed chemo and interventional delivery reduce toxicity • Why precision oncology requires extensive physician training 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

    10 min
  6. JAN 30

    Cancer Clinical Trials: The $500B Scandal Exposed

    When you hear the words “clinical trial,” you’re told it might be your breakthrough. But what most patients aren’t told is how clinical trials actually work — and what their limitations are. In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, explains the good, the bad, and the uncomfortable truth about cancer clinical trials. Most trials are designed to test one drug against one marker, even though cancer uses dozens of pathways to survive, spread, and resist treatment. Patients with the same cancer and stage often have completely different molecular drivers — yet trials rarely account for that complexity. Dr. Prato contrasts the traditional trial model with N-of-1 precision oncology, where treatment is custom-built around your biology using deep multi-omics testing: DNA sequencing, RNA transcriptomics, immune profiling, and spatial biology. Instead of slowing cancer temporarily with cytostatic drugs, this approach focuses on immune-centric, cytotoxic strategies designed to expose cancer to the immune system and eliminate it. You’ll also learn why fewer than 10% of adult cancer patients ever enroll in trials, why many drugs fail late in development, and why maximum-dose testing often creates unnecessary toxicity. Precision oncology flips that model — using the smallest effective dose, the right combinations, and real-time monitoring to improve quality of life and long-term response. 🎯 What You’ll Learn in This Episode: • How cancer clinical trials are designed — and their built-in limitations • Why most new cancer drugs are cytostatic, not cytotoxic • Why two patients with the same cancer rarely need the same treatment • What N-of-1 precision oncology really means • How deep DNA, RNA, immune & spatial testing changes outcomes • Why immune-centric care matters more than one “breakthrough” drug • The right questions to ask before entering a clinical trial 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak with a care coordinator: 866-830-4576 “Clinical trials look for one drug that works for many. Precision oncology builds the right plan for you.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

    16 min
  7. JAN 29

    A Dose of Reality — Inside the Cancer Industry | Dr. Dino Prato Exposes the Truth

    Chemotherapy didn’t start in a clinic — it started in a war. In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, pulls back the curtain on the origins of modern oncology and why, 80 years later, the system still relies on the same high-dose, population-based model born from wartime poisons. From the discovery of mustard gas toxicity in 1942 to today’s billion-dollar chemotherapy industry, Dr. Prato exposes how the “sick care cartel” — pharmaceutical companies, PBMs, and hospital systems — profits from managing cancer rather than curing it. But there’s a new model rising: immune-centric precision oncology. Dr. Prato explains how deep multi-omics mapping (DNA, RNA, immune, and spatial biology) replaces guesswork with custom-built, low-toxicity treatments that awaken the body’s immune system — turning “maximum tolerated dose” into minimum effective precision. 🎯 What You’ll Learn in This Episode: • The wartime origins of chemotherapy and why that model still drives care today • Why most new cancer drugs only extend life by months on average • How PBMs and hospital markups distort care and inflate costs • The difference between cytostatic and cytotoxic treatments — and why it matters • How microdosed, immune-centric precision care rebuilds the body instead of breaking it • Why DNA/RNA testing and spatial biology are the key to custom-built therapy 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak to a care coordinator: 866-830-4576 “The war on cancer was never meant to end — until precision changed the rules.” Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

    11 min
  8. JAN 28

    Beating Breast Cancer Twice — Why Precision Care Prevents Recurrence

    Imagine beating breast cancer — only for it to come back a year later in the other breast. In this episode of Outsmart Cancer, Dr. Dino Prato, founder of Envita Medical Centers, exposes why so many breast cancer patients relapse — and how precision oncology could have prevented it. Standard protocols and limited RNA blood tests often miss key drivers, leaving patients on the wrong medications 90% of the time. Dr. Prato reveals how Envita’s OncoMeta precision ecosystem uses DNA/RNA sequencing, immune spatial biology, and adaptive monitoring to detect the smallest signs of recurrence before it happens. Instead of another round of toxic chemo and surgery, patients receive custom-designed, microdosed therapies like Genetically Targeted Fractionated Chemotherapy (GTFC), cryoablation, and immune retraining to destroy cancer while preserving strength. 🎯 What You’ll Learn in This Episode: • Why standard testing misses hidden tumor drivers • The critical role of immune typing and spatial biology • How OncoMeta connects testing, drug design, and delivery in one system • Why cryoablation can replace surgery and preserve immune antigens • How circulating tumor cell monitoring prevents relapse early • Why precision care restores health while protecting the immune system 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: www.envita.com 📞 Speak to a care coordinator: 866-830-4576 Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperinformation?paperid=132493

    16 min

Ratings & Reviews

5
out of 5
2 Ratings

About

OutSmart Cancer is the podcast for people who refuse to settle for one-size-fits-all cancer care. Hosted by Dr. Dino Prato, founder of Envita Medical Centers, this show offers expert insight into the world of precision oncology, integrative treatments, and the hidden factors that make cancer so hard to treat — and what to do about them. For the last 25 years, Dr. Prato and his team have helped thousands of patients that have failed the largest hospitals utilizing the techniques and technology discussed in this series. Whether you’ve been newly diagnosed, are navigating treatment resistance, or want a second opinion grounded in science and compassion, you’ll hear empowering discussions on: DNA, RNA, and immune-based targeting, the truth behind standard protocols, what most doctors miss in treatment planning, stories of hope from patients who’ve been told “there’s nothing more we can do” We believe in personalized, data-driven medicine — not protocol-based guessing.You don’t have to fight cancer blindly. You can OutSmart it. Disclaimer:  This podcast is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before making medical decisions. Results vary and no specific outcomes are guaranteed. Some treatments may not be FDA-approved or available in all locations. Testimonials reflect individual experiences and may not represent typical outcomes. Certain therapies may be offered only at Envita’s international clinic in Hermosillo, Mexico.